Announcement on behalf of OBIGEN Pharma of the BOD’s resolution to lift the non-competition restrictions for CEO

Date of the board of directors resolution:2025/02/18 Name and title of the managerial officer with permission to engage in competitive conduct: Patricia Chou / CEO Items of competitive conduct in which the officer is permitted to engage:Scope of business is similar to that of OBIGEN Pharma Period of permission to engage in the competitive conduct:Duration […]